Statistics
Publications
73
Citations
3.4K
H-Index
32
Active since
1982
Takayoshi Okabe is an author at The University of Tokyo specializing in medicine, drug discovery, and pharmacology.
Publications per year
1982–2023
73
73
Butyrolactone I, a selective inhibitor of cdk2 and cdc2 kinase.
Masatoshi Kitagawa, Takayoshi Okabe, H Ogino et al. · PubMed · 1993 · 221 citations
1–5 of 73